Frailty and glaucoma may have a proportional relationship, and patients with higher frailty metrics may face significant barriers to regular eye screening and disease management.

Adults with type 2 diabetes (T2D) have an increased risk for mortality in association with low income, with the most prominent increase seen for adults aged 20 to 39 years.

HealthDay News — The frequency of medical board discipline for physician-spread misinformation is low, according to a study published online Nov. 12 in JAMA Network Open.

Characters with strabismus are often portrayed in animated movies and are significantly more likely to be portrayed negatively than positively.

The genetic testing rate is lower for Black than non-Hispanic White patients with inherited retinal diseases (IRDs). HealthDay News — The genetic testing rate is lower for Black than non-Hispanic ...

The Valeda ® Light Delivery System (LumiThera, Inc.) is the first ever FDA-authorized treatment for vision loss in dry AMD, the manufacturer reported. The technology was evaluated in the LIGHTSITE III ...

The Prescription Drug User Fee Act date refers to the deadline set by the FDA for reviewing a NDA or Biologics License Application.

Glaucoma prevalence appears higher than prior research has estimated, with approximately 4.22 million US adults affected.

More than one-third of patients admitted to the hospital for surgery have adverse events, with more than half potentially preventable.

The number of Americans sickened in an E. coli outbreak tied to slivered onions used on McDonald's Quarter Pounders has now risen to 104.

For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a lower risk for venous thromboembolism (VTE).

There was an increase in dyslipidemia incidence during the COVID-19 pandemic compared with the prepandemic period.